Design of an implantable active microport system for patient specific drug release

We present a novel concept of an implantable active microport based on micro technology that incorporates a high-resolution volumetric dosing unit and a drug reservoir into the space of a conventional subcutaneous port. The controlled release of small drug volumes from such an “active microport” is crucial e.g. for innovative methods in cancer treatment or pain therapy. Our microport system delivers a flow rate in the range of 10–1,000 μl/h and enables a patient-specific release profile. The core of our device is a two-stage piezoelectric micropump. It features a backpressure-independent volumetric dosing capability i.e. a stable flow rate is ensured up to a backpressure of 30 kPa. The stroke volume and hence the resolution of the mircopump is voltage controlled and can be preset between 10 and 200 nl. A miniaturized high-performance electronic control unit enables freely programmable dosing profiles. This electronic circuit is optimized for both energy consumption and weight which are both essential for a portable device. The data of an implemented pressure sensor are used to permanently monitor the dosing process and to detect a potential catheter occlusion. A polyurethane soft lithography process is introduced for the fabrication of the prototype. Therewith, a compact multilayer system has been developed which measures only 50 × 35 × 25 mm3.

[1]  Peter Woias,et al.  A Piezoelectric Bidirectional Micropump for a Medical Application , 2004 .

[2]  R. Mason,et al.  Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. , 2005, Neoplasia.

[3]  J. Drevs,et al.  Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. , 2004, Anticancer research.

[4]  M. Ferrari Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[5]  R. Kerbel,et al.  Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. , 2002, Cancer research.

[6]  D. Ribatti,et al.  Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. , 2003, Cancer research.

[7]  H. Struijker‐Boudier,et al.  Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data. , 2001, British journal of clinical pharmacology.

[8]  M. Moser,et al.  Why Life Oscillates – from a Topographical Towards a Functional Chronobiology , 2006, Cancer Causes & Control.

[9]  R. Zengerle,et al.  Novel approaches to microfluidic components in high-end medical applications , 2003, TRANSDUCERS '03. 12th International Conference on Solid-State Sensors, Actuators and Microsystems. Digest of Technical Papers (Cat. No.03TH8664).

[10]  Peter Woias,et al.  A generic analytical model for micro-diaphragm pumps with active valves , 2005 .

[11]  Francis Lévi,et al.  Chronotherapeutics: The Relevance of Timing in Cancer Therapy , 2006, Cancer Causes & Control.

[12]  Ming Lei,et al.  Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. , 2004, Advanced drug delivery reviews.

[13]  F. Goldschmidtboeing,et al.  Low temperature plasma-assisted wafer bonding and bond-interface stress characterization , 2004, 17th IEEE International Conference on Micro Electro Mechanical Systems. Maastricht MEMS 2004 Technical Digest.

[14]  M. Cima,et al.  A controlled-release microchip , 1999, Nature.

[15]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[16]  Sunita Chauhan,et al.  International Conference on Biomedical Engineering , 2005 .

[17]  S. Gamper,et al.  A high-performance silicon micropump for disposable drug delivery systems , 2001, Technical Digest. MEMS 2001. 14th IEEE International Conference on Micro Electro Mechanical Systems (Cat. No.01CH37090).

[18]  Gabriele Bergers,et al.  Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. , 2000, The Journal of clinical investigation.

[19]  F. Forni,et al.  Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates. , 1999, International journal of pharmaceutics.

[20]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  L. Lin,et al.  A water-powered micro drug delivery system , 2004, Journal of Microelectromechanical Systems.

[22]  D. Harrison,et al.  Circulatory response to vasodilator therapy in congestive cardiomyopathy. , 1976, British heart journal.

[23]  M. Ferrari,et al.  Nanopore Technology for Biomedical Applications , 1999 .

[24]  Cornelia M Keck,et al.  Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. , 2004, Journal of biotechnology.

[25]  Peter Woias,et al.  A novel two-stage backpressure-independent micropump: modeling and characterization , 2007 .

[26]  N. Lobontiu Mechanics of microelectromechanical systems , 2004 .

[27]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.